Abridge inks deals with Nvidia and Lilly

Abridge inks deals with Nvidia and Lilly

https://www.statnews.com/2026/06/11/abridge-inks-deals-with-nvidia-and-lilly/

Publish Date: 2026-06-11 16:19:00

Source Domain: www.statnews.com

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

NEW YORK — Health care artificial intelligence company Abridge on Thursday announced new deals with two trillion-dollar companies, pharma giant Eli Lilly and chipmaker Nvidia, as it aims to gain an edge in the competitive market for software that supports doctors and streamlines hospital billing and operations.

Abridge, which is used by hundreds of health systems, devoted much of a midtown Manhattan event to demonstrating new elements of its platform that documents patient visits and offers guidance and suggestions to clinicians before, during, and after a visit.

But the billboard announcements were partnerships. Draped head-to-toe in black, on a day forecast to be in the 90s, Abridge CEO Shiv Rao announced that Eli Lilly had made a strategic investment in the company, and that Abridge had a new collaboration with Nvidia to develop “the first foundation model purpose-built for clinical conversations.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Source